Drug
Sage 904
Sage 904: highest development phase Phase 1, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| SAGE-904 NCT05049343 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Sage 904 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.